| Date | Time | Source | Headline | Symbol | Company |
| 10/16/2009 | 1:40PM | Edgar (US Regulatory) | (25-NSE) | NYSE:WYE | Wyeth |
| 10/15/2009 | 5:05PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:WYE | Wyeth |
| 10/15/2009 | 5:00PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:WYE | Wyeth |
| 10/15/2009 | 4:45PM | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | NYSE:WYE | Wyeth |
| 10/15/2009 | 12:46PM | Dow Jones News | Pfizer Completes Acquisition Of Wyeth | NYSE:WYE | Wyeth |
| 10/15/2009 | 11:49AM | Business Wire | Pfizer Completes Acquisition Of Wyeth | NYSE:WYE | Wyeth |
| 10/15/2009 | 9:38AM | Marketwired | Stock on the Move: SUWN - October 15, 2009 | NYSE:WYE | Wyeth |
| 10/15/2009 | 6:09AM | Marketwired | Global Market Perspective Review on WYE, WTSLA, TIVO, TIBX, SWHC and SVNT from TheFortuneFinancial.com | NYSE:WYE | Wyeth |
| 10/15/2009 | 6:02AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NYSE:WYE | Wyeth |
| 10/14/2009 | 4:24PM | Dow Jones News | 2nd UPDATE: FTC Clears Pfizer-Wyeth Deal, With Conditions | NYSE:WYE | Wyeth |
| 10/14/2009 | 1:47PM | Dow Jones News | UPDATE: US FTC Clears Pfizer-Wyeth Deal, With Conditions | NYSE:WYE | Wyeth |
| 10/14/2009 | 1:37PM | DPA AFX Nachrichten | Pfizer macht US-Wettbewerbsbehörde Zugeständnisse bei Wyeth-Übernahme | NYSE:WYE | Wyeth |
| 10/14/2009 | 12:53PM | Dow Jones News | FTC Clears Pfizer-Wyeth Deal, With Conditions | NYSE:WYE | Wyeth |
| 10/09/2009 | 4:20PM | Dow Jones News | UPDATE: Pfizer Halts Enrollment In Lung-Cancer Drug Trial | NYSE:WYE | Wyeth |
| 10/09/2009 | 2:47PM | Dow Jones News | Pfizer Halts Enrollment In Lung-Cancer Drug Trial | NYSE:WYE | Wyeth |
| 10/06/2009 | 7:22AM | Marketwired | BenchmarkJournal.com Free Analyst Review for IR, WDR, JCG, WYE, HOG and TWX | NYSE:WYE | Wyeth |
| 10/05/2009 | 4:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:WYE | Wyeth |
| 10/02/2009 | 4:21PM | DPA AFX Nachrichten | ROUNDUP/Aktien New York Schluss: Knapp behauptet - Konjunkturdaten enttäuschen | NYSE:WYE | Wyeth |
| 10/02/2009 | 11:00AM | DPA AFX Nachrichten | ROUNDUP/Aktien New York: Uneinheitlich - US-Daten enttäuschen, Apple gefragt | NYSE:WYE | Wyeth |
| 10/02/2009 | 2:25AM | Dow Jones News | UK's NICE Recommends Use Of GlaxoSmithKline's Hycamtin | NYSE:WYE | Wyeth |
| 09/29/2009 | 5:04PM | Dow Jones News | 2nd UPDATE:SEC Subpoenas Elan For Tysabri Infection Case Info | NYSE:WYE | Wyeth |
| 09/29/2009 | 3:30PM | Dow Jones News | UPDATE: SEC Subpoenas Elan For Records Of Tysabri Infection Cases | NYSE:WYE | Wyeth |
| 09/29/2009 | 1:59PM | Dow Jones News | SEC Subpoenas Elan For Records Of Tysabri Infection Cases | NYSE:WYE | Wyeth |
| 09/25/2009 | 12:42PM | Dow Jones News | CORRECT:EU Panel OKs Authorisation For Multaq,From Sanovi-Aventis | NYSE:WYE | Wyeth |
| 09/25/2009 | 11:58AM | Dow Jones News | EU Panel OKs Authorisation For Multaq,From Sanovi-Aventis | NYSE:WYE | Wyeth |
| 09/25/2009 | 11:08AM | PR Newswire (US) | Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young | NYSE:WYE | Wyeth |
| 09/23/2009 | 2:43PM | Dow Jones News | Schering's Hassan Stresses Innovation In Success For Pharma | NYSE:WYE | Wyeth |
| 09/23/2009 | 11:57AM | Dow Jones News | UPDATE: Wyeth Sues FDA Seeking To Reverse Zosyn Approval | NYSE:WYE | Wyeth |
| 09/23/2009 | 10:28AM | Dow Jones News | Wyeth Sues FDA Seeking To Reverse Approval Of Generic Zosyn | NYSE:WYE | Wyeth |
| 09/23/2009 | 5:55AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of WYE, UIS, ACN, LO, AEO and XOMA | NYSE:WYE | Wyeth |